3M Results Presentation Deck

Creating a diversified healthcare technology leader 2021 Sales ~$8.6.B 1 2021 EBITDA ~$2.7B 2021 EBITDA Margin ~31% 1 - Includes Food Safety (~$0.4B), expected to be divested by Sept. 1, 2022, that will no longer be part of Health Care 2022 Q2 Earnings - July 26, 2022. All rights reserved. Health Care Core Strengths: Proven leadership in multiple care pathways Positioning in attractive end-markets Innovation mindset driving improved patient outcomes Collaborative customer relationships Deep global regulatory expertise Operational excellence and strong cash flow Strong sales growth and profitability with significant recurring sales ● ● ● ● 3M 11

View entire presentation